PACLX | TPPAX | PACLX / TPPAX | |
Total Expense Ratio | 0.97 | 0.62 | 156% |
Annual Report Gross Expense Ratio | 0.99 | 0.80 | 124% |
Fund Existence | 20 years | 9 years | - |
Gain YTD | -2.291 | -2.013 | 114% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 500000 | 1% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 62.3B | 1.89B | 3,303% |
Annual Yield % from dividends | 1.92 | 2.63 | 73% |
Returns for 1 year | -1.46 | 0.53 | -275% |
Returns for 3 years | 3.06 | 4.66 | 66% |
Returns for 5 years | 21.90 | 16.91 | 130% |
Returns for 10 years | 39.82 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
GLO | 4.76 | 0.11 | +2.37% |
Clough Global Opportunities Fund | |||
MARW | 30.42 | 0.20 | +0.65% |
AllianzIM U.S. Large Cp Buffer20 Mar ETF | |||
FTXH | 24.63 | 0.08 | +0.33% |
First Trust Nasdaq Pharmaceuticals ETF | |||
PYLD | 25.87 | 0.04 | +0.15% |
PIMCO Multisector Bond Active ETF | |||
ASA | 29.55 | -0.84 | -2.76% |
ASA Gold AND Precious Metals Limited |